Statins reshape the tumor microenvironment (TME) by reprogramming tumor‐associated macrophages (TAMs) from a tumor‐promoting M2 phenotype to an antitumor M1 phenotype, which enhances immune responses against cancer cells. This evidence concerns the gene EEF1A2 and neoplasm.